Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin vs Somatostatin on Portal Pressure in Liver Transplantation
NCT07304466Recruiting
- Sponsor
- Medipol Mega University Hospital
- Start
- Dec 2025
- Primary completion
- Mar 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Portal Hypertension (PH) comparing Group Somatostatin (SS) with Group Terlipressin (TR) (2 arms). Primary endpoint: Decrease in portal pressure by 20% from the baseline. Started Dec 2025; status: recruiting.
02
Drugs
terlipressinsomatostatin
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT07304466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07304466.